Your browser doesn't support javascript.
loading
Functionalized solid lipid nanoparticles combining docetaxel and erlotinib synergize the anticancer efficacy against triple-negative breast cancer.
Chaudhuri, Aiswarya; Naveen Kumar, Dulla; Kumar, Dinesh; Kumar Agrawal, Ashish.
Affiliation
  • Chaudhuri A; Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi 221005, India.
  • Naveen Kumar D; Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi 221005, India.
  • Kumar D; Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi 221005, India.
  • Kumar Agrawal A; Department of Pharmaceutical Engineering & Technology, IIT (BHU), Varanasi 221005, India. Electronic address: ashish.phe@iitbhu.ac.in.
Eur J Pharm Biopharm ; 201: 114386, 2024 Aug.
Article in En | MEDLINE | ID: mdl-38950717
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Particle Size / Drug Synergism / Nanoparticles / Triple Negative Breast Neoplasms / Drug Liberation / Erlotinib Hydrochloride / Docetaxel / Lipids Limits: Female / Humans Language: En Journal: Eur J Pharm Biopharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: India Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Particle Size / Drug Synergism / Nanoparticles / Triple Negative Breast Neoplasms / Drug Liberation / Erlotinib Hydrochloride / Docetaxel / Lipids Limits: Female / Humans Language: En Journal: Eur J Pharm Biopharm Journal subject: FARMACIA / FARMACOLOGIA Year: 2024 Document type: Article Affiliation country: India Country of publication: Países Bajos